Bradykinin potentiation by angiotensin-(1-7) and ACE inhibitors correlates with ACE C- and N-domain blockade

Hypertension

Volumn 38, Issue 1, 2001, Pages 95-99

  Tom, Beril ^a   De Vries, René ^a   Saxena, Pramod R ^a   Danser, A H Jan ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Angiotensin; Angiotensin converting enzyme inhibitors; Bradykinin; Coronary artery; Receptors, bradykinin

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN[1-7]; BRADYKININ; BRADYKININ B2 RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; PROSTAGLANDIN F2 ALPHA; QUINAPRILAT; VASODILATOR AGENT;

ADOLESCENT; ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SWINE; VASODILATATION;

EID: 0035569026     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.38.1.95     Document Type: Article

References (24)

1. Counterregulatory actions of angiotensin-(1-7)
2. Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide
3. Angiotensin-(1-7) induces bradykinin-mediated relaxation in porcine coronary artery
4. Corrigendum
5. Angiotensin-(1-7) is a modulator of the human reninangiotensin system
6. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man
7. Effect of angiotensin-(1-7) and bradykinin in patients with heart failure treated with an ACE inhibitor
8. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: Angiotensin-(1-7) and keto-ACE
9. 2 receptors and angiotensin-converting enzyme in CHO cells
10. 2 kinin receptor within the plasma membrane of native endothelial cells
11. L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: Effect of ACE inhibition
12. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme
13. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme
14. Substrate dependence of angiotensin 1-converting enzyme inhibition: Captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl prolinc hydrolysis compared with that of angiotensin I
15. ID receptors in the sumatriptan-induced constriction of porcine carotid arteriovenous anastomoses
16. Vasoconstriction by in situ formed angiotensin II role of ACE and chymase
17. Simultaneous analysis of families of sigmoidal curves: Application to bioassay, radioligand assay, and physiological dose-response curves
18. Nephrectomy, converting enzyme inhibition, and angiotensin peptides
19. An alternative strategy for the immunoassay of angiotensin peptides using amino-terminal-directed antisera: Measurement of eight angiotensin peptides in human plasma
20. Angiotensin-converting enzyme inhibition modifies angiotensin but not kinin peptide levels in human atrial tissue
21. Converting enzyme determines plasma clearance of angiotensin-(1-7)
22. Differences in the properties and enzymatic specificities of the two active sites of angiotensin I-converting enzyme (kininase II): Studies with bradykinin and other natural peptides
23. 2 receptor
24. 2 bradykinin receptor by ACE inhibitors